Feb 2, 2026
Serious vs Non-Serious Adverse Events: When to Report in Clinical Trials
Myasthenia gravis is an autoimmune disorder that disrupts nerve-to-muscle communication. Modern treatments now include targeted biologics, thymectomy, and immunosuppressants-offering real hope for remission and improved quality of life.